Úvod Laboratorní plasty Zkumavky Microcentrifuge Tube 1.5 ml Microcentrifuge Tube SALSA MLPA P372 Microdeletion-6 probemix - 100 reactions

SALSA MLPA P372 Microdeletion-6 probemix - 100 reactions

SALSA MLPA P372 Microdeletion-6 probemix - 100 reactions

application: Microdeletion follow-up

region: Sotos, DiGeorge, Rubinstein-Taybi, NF1 Detailní informace

Cena s DPH € 1 147.08
Cena bez DPH € 948.00
 100 react
Dostupnost Skladem
Kód produktu P372-100R

Nejnovější informace o produktu naleznete exklusivně na stránkách výrobce MRC-Holland www.mlpa.com (nové okno)

Detailní popis SALSA MLPA P372 Microdeletion-6 probemix - 100 reactions

P372-025R SALSA MLPA P372 Microdeletion syndromes 6 probemix – 100 rxn

description
The purpose of the P372 probemix is to further investigate results found with the P245 Microdeletion probemix. The P245-A version probemix provides a possibility to screen samples for 21 different microdeletion syndromes in a single reaction. For confirmation of results obtained with this P245 probemix, four different probemixes are now available with additional probes in these 21 regions: P371, P372, P373 and P374 Microdeletion syndromes.

This P372 probemix contains probes for the Sotos syndrome region on 5q35 (7 probes), the DiGeorge region on 22q11 (18 probes), the Rubinstein-Taybi CREBBP gene on 16p13 (7 probes), the DiGeorge 2 region on 10p14 (6 probes) and the NF1 gene region on 17q (10 probes).

This SALSA® MLPA® probemix is designed to detect deletions/duplications of one or more sequences in the aforementioned regions in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak area of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak area, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings.

Kontaktujte nás

BIOGEN PRAHA s.r.o.
Ke sv. Izidoru 2293/4A
140 00 PRAHA 4

Tel.: +420 241 401 693
Fax: +420 241 401 694
E-mail: biogen@biogen.cz

Novinky na e-mail

Vaše osobní údaje nejsou nikde zveřejňovány a splňují požadavky GDPR.